Literature DB >> 12410825

A novel assembly process of the multicomponent xenobiotic efflux pump in Pseudomonas aeruginosa.

Hideaki Maseda1, Masataka Kitao, Shima Eda, Eisaku Yoshihara, Taiji Nakae.   

Abstract

The nfxC-type cells of Pseudomonas aeruginosa show resistance to a wide range of structurally and functionally diverse antibiotics, which is a phenomenon that is mainly attributable to the expression of the MexEF-OprN xenobiotic transporter. The MexF, MexE and OprN subunits of this transporter are located on the inner membrane, the periplasm and the outer membrane, respectively, and are assumed to function as an energy-dependent transporter, a bridge connecting the inner and outer membranes and outer membrane channel respectively. The nfxC-type cells showed a single protein band of MexF and OprN, whereas MexE appeared as three distinct bands in an SDS-polyacrylamide gel electrophoretogram. The mutant cells lacking MexF produced undetectable OprN and only a full-size of MexE even though the cells had unimpaired oprN and mexE. Expression of the plasmid-borne MexF in this mutant fully restored OprN and three MexE bands. Another class of mutants producing a full amount of MexF yielded undetectable OprN and two MexE bands lacking the smallest protein species suggesting that the presence of the smallest MexE subunit is required for stabilization of OprN. To identify which part of MexE was needed for stabilization and assembly of OprN, the carboxyl-terminal-truncated MexE tagged with polyhistidine was constructed and protein bands were visualized in the presence of MexF with an antibody raised against polyhistidine or MexE. The results revealed that the proteolytic processing of MexE would occur at carboxyl terminal amino acids between 11 and 16, thereby suggesting that the presence of the C-terminal truncated MexE is essential for stabilization and the proper assembly of OprN. Nucleotide sequencing of mutant mexFs, which produce a wild-type level of MexF but are unable to support the production of the smallest MexE, thereby destabilizing OprN, revealed that all the mutations were located within two large periplasmic domains of MexF between transmembrane segments 1-2 and 7-8. Taking these findings together, we concluded that two large periplasmic domains of MexF interact with MexE thereby promoting programmed processing of MexE, and this complex eventually assists the correct assembly and sorting of OprN.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410825     DOI: 10.1046/j.1365-2958.2002.03197.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  5 in total

1.  Chimeric analysis of AcrA function reveals the importance of its C-terminal domain in its interaction with the AcrB multidrug efflux pump.

Authors:  Christopher A Elkins; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

Review 2.  Efflux-mediated drug resistance in bacteria.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Molecular analysis of the copper-transporting efflux system CusCFBA of Escherichia coli.

Authors:  Sylvia Franke; Gregor Grass; Christopher Rensing; Dietrich H Nies
Journal:  J Bacteriol       Date:  2003-07       Impact factor: 3.490

4.  Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa.

Authors:  Hideaki Maseda; Isao Sawada; Kohjiro Saito; Hiroo Uchiyama; Taiji Nakae; Nobuhiko Nomura
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

5.  Microbial responses to xenobiotic compounds. Identification of genes that allow Pseudomonas putida KT2440 to cope with 2,4,6-trinitrotoluene.

Authors:  Matilde Fernández; Estrella Duque; Paloma Pizarro-Tobías; Pieter Van Dillewijn; Rolf-Michael Wittich; Juan L Ramos
Journal:  Microb Biotechnol       Date:  2009-03       Impact factor: 5.813

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.